Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1111/ACER.15516 | ||||
| Año | 2025 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Background To investigate the trends in alcohol-associated liver disease (ALD), liver cancer from alcohol, and alcohol use disorder (AUD) burden among older adults in the United States (US). Methods We gathered the ALD, liver cancer from alcohol, and AUD prevalence, mortality, and age-standardized rates (ASRs) from the Global Burden of Disease (GBD) Study 2021 between 2010 and 2021. We estimated the annual percent change (APC) with confidence intervals (CIs) for the burden of ALD, liver cancer from alcohol, and AUD in older adults (>70 years) in the United States. The findings were contrasted with global estimates and categorized by sex and state. Results In 2021, there were approximately 512,340 cases of AUD, 56,990 cases of ALD, and 4490 cases of primary liver cancer from alcohol among older adults in the United States. In contrast to declining ASRs of prevalence and mortality in the global burden, these parameters were increased in older adults in the United States. From 2000 to 2021, prevalence from AUD (APC: 0.54%, 95% CI 0.43% to 0.65%), ALD (APC + 0.54%, 95% CI 0.22% to 0.86%), and primary liver cancer from alcohol (APC 2.93%, 95% CI 2.76% to 3.11%) increased. Forty states in the United States exhibited a rise in the prevalence rates of ALD in older adults. Conclusion Our findings highlighted the increased prevalence and mortality of AUD, ALD, and primary liver cancer from alcohol among older adults in the United Sates, contrasting with the decline in global trends. Public health strategies on ALD, AUD, and primary liver cancer from alcohol, which targets older adults, are urgently needed.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Danpanichkul, Pojsakorn | - |
TEXAS TECH UNIV - Estados Unidos
TTUHSC School of Medicine - Estados Unidos |
| 2 | Duangsonk, Kwanjit | - |
Chiang Mai Univ - Tailandia
Faculty of Medicine, Chiang Mai University - Tailandia |
| 3 | Tham, Ethan Kai Jun | - |
Natl Univ Singapore - Singapur
NUS Yong Loo Lin School of Medicine - Singapur |
| 4 | Tothanarungroj, Primrose | - |
Chiang Mai Univ - Tailandia
Faculty of Medicine, Chiang Mai University - Tailandia |
| 5 | Auttapracha, Thanida | - |
Chiang Mai Univ - Tailandia
Faculty of Medicine, Chiang Mai University - Tailandia |
| 6 | Prasitsumrit, Vitchapong | - |
Mahidol Univ - Tailandia
Siriraj Hospital - Tailandia |
| 7 | Sim, Benedix | - |
Natl Univ Singapore - Singapur
Natl Univ Hlth Syst - Singapur NUS Yong Loo Lin School of Medicine - Singapur National University Health System - Singapur |
| 8 | Tung, Daniel | - |
Natl Univ Singapore - Singapur
Natl Univ Hlth Syst - Singapur NUS Yong Loo Lin School of Medicine - Singapur National University Health System - Singapur |
| 9 | Barba, Romelia | - |
TEXAS TECH UNIV - Estados Unidos
TTUHSC School of Medicine - Estados Unidos |
| 10 | Wong, Robert J. | - |
Vet Affairs Palo Alto Healthcare Syst - Estados Unidos
Stanford Univ - Estados Unidos VA Palo Alto Health Care System - Estados Unidos Indiana University School of Medicine - Estados Unidos Stanford University School of Medicine - Estados Unidos |
| 11 | Leggio, Lorenzo | - |
NIDA - Estados Unidos
NIAAA - Estados Unidos National Institute on Drug Abuse (NIDA) - Estados Unidos |
| 12 | Yang, Ju Dong | - |
Cedars Sinai Med Ctr - Estados Unidos
Cedars-Sinai Medical Center - Estados Unidos |
| 13 | Chen, Vincent L. | - |
UNIV MICHIGAN - Estados Unidos
University of Michigan Medical School - Estados Unidos |
| 14 | Noureddin, Mazen | - |
Houston Res Inst - Estados Unidos
Houston Methodist Hosp - Estados Unidos Houston Methodist Hospital - Estados Unidos |
| 15 | Diaz, Luis Antonio | - |
Pontificia Universidad Católica de Chile - Chile
OMEGA - Chile Univ Calif San Diego - Estados Unidos Escuela de Medicina - Chile Observatorio Multicéntrico de Enfermedades Gastrointestinales (OMEGA) - Chile University of California, San Diego - Estados Unidos |
| 16 | Arab, Juan Pablo | - |
Pontificia Universidad Católica de Chile - Chile
OMEGA - Chile Virginia Commonwealth Univ - Estados Unidos Escuela de Medicina - Chile Observatorio Multicéntrico de Enfermedades Gastrointestinales (OMEGA) - Chile TTUHSC School of Medicine - Estados Unidos VCU School of Medicine - Estados Unidos |
| 17 | Wijarnpreecha, Karn | - |
UNIV ARIZONA - Estados Unidos
Banner Univ - Estados Unidos University of Arizona College of Medicine – Phoenix - Estados Unidos Banner - University Medical Center Phoenix - Estados Unidos |
| 18 | Liangpunsakul, Suthat | - |
Indiana Univ Sch Med - Estados Unidos
Richard L Roudebush Vet Adm Med Ctr - Estados Unidos Indiana University School of Medicine - Estados Unidos Richard L. Roudebush VAMC - Estados Unidos |
| Fuente |
|---|
| National Institute on Drug Abuse |
| National Institutes of Health |
| National Institute on Alcohol Abuse and Alcoholism |
| NIAAA |
| U.S. Department of Veterans Affairs |
| AstraZeneca |
| Kowa Company |
| School of Medicine, Indiana University |
| Department of Veterans Affairs Merit Award |
| National Institutes of Health Intramural Research Program (NIDA) |
| Dean's Scholar from Indiana University School of Medicine |
| National Institutes of Health Intramural Research Program (NIAAA) |
| Agradecimiento |
|---|
| This work is partly supported by grants U01AA026917, UH2/UH3 AA026903, R01AA030312, and R21AA031370 from the NIAAA and Department of Veterans Affairs Merit Award 1I01CX000361 and I01 BX006202 and Dean's Scholar from Indiana University School of Medicine (SL). Lorenzo Leggio is a US federal employee and is funded by the National Institutes of Health Intramural Research Program (NIDA and NIAAA). |
| This work is partly supported by grants U01AA026917, UH2/UH3 AA026903, R01AA030312, and R21AA031370 from the NIAAA and Department of Veterans Affairs Merit Award 1I01CX000361 and I01 BX006202 and Dean's Scholar from Indiana University School of Medicine (SL). Lorenzo Leggio is a US federal employee and is funded by the National Institutes of Health Intramural Research Program (NIDA and NIAAA). |
| This work is partly supported by grants U01AA026917, UH2/UH3 AA026903, R01AA030312, and R21AA031370 from the NIAAA and Department of Veterans Affairs Merit Award 1I01CX000361 and I01 BX006202 and Dean's Scholar from Indiana University School of Medicine (SL). Lorenzo Leggio is a US federal employee and is funded by the National Institutes of Health Intramural Research Program (NIDA and NIAAA). |